A Multicentric Experience on Living Donor Liver Transplantation in Coronavirus Disease 2019 Hotspots in India
Liver Transpl
.
2021 Sep;27(9):1334-1338.
doi: 10.1002/lt.25957.
Epub 2021 Feb 15.
Authors
Joy Varghese
1
,
Selvakumar Malleeswaran
1
,
Rajanikanth V Patcha
1
,
Ellango Appusamy
1
,
Perumal Karnan
1
,
Dharmesh Kapoor
2
,
Kota Venugopal
2
,
Chandhan Kumar Kedarisetty
2
,
Balbir Singh
2
,
Prashantha S Rao
2
,
Raghavendra Babu Yalakanti
2
,
Ravi Mohanka
3
,
Anurag Shrimal
3
,
Vinayak Nikam
3
,
Karan Kumar
4
,
Sunil D Shenvi
4
,
Bhaskaran Pillai Venugopal
4
,
Nigel D Heaton
5
Affiliations
1
Institute of Liver Disease & Transplantation, Gleneagles Global Health City, Chennai, India.
2
Department of Hepatology & Transplantation, Gleneagles Global Health City, Hyderabad, India.
3
Department of Liver Transplant & Hepatobiliary Surgery, Gleneagles Global Health City, Mumbai, India.
4
Department of Hepato-pancreato-biliary & Transplant Surgery, BGS Gleneagles Global Hospital, Bengaluru, India.
5
Institute of Liver Studies, King's College Hospital, London, UK.
PMID:
33253477
PMCID:
PMC7753810
DOI:
10.1002/lt.25957
No abstract available
MeSH terms
COVID-19*
Humans
India / epidemiology
Liver Transplantation*
Living Donors
SARS-CoV-2
Tissue and Organ Procurement*